ProCE Banner Activity

Updates on FDA-Approved Obesity Pharmacotherapies

Slideset

In these unlocked downlodable slides, experts review new and FDA-approved pharmacotherapy for the treatment of obesity and describe best practices for use.

Released: June 09, 2023

Share

Faculty

Megan Adelman

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Clinical Pharmacist - Family Medicine
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

W. Scott Butsch

W. Scott Butsch, MD, MSc

Director of Obesity Medicine 
Bariatric and Metabolic Institute
Cleveland Clinic 
Cleveland, Ohio 

Susan M. Tiso

Susan M. Tiso, DNP, APRN, FNP-BC, FAANP

Clinical Professor, Retired
Sue & Bill Gross School of Nursing
Family Nurse Practicioner, Retired
Family Medicine 
University of California, Irvine 
Irvine, California 

Provided by

This activity is provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, ProCE, LLC and Q Synthesis.

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner

Q Synthesis LLC

ProCE Banner